Regular Article
Constitutive Activation of Wnt/β-Catenin Signaling Pathway in Migration-Active Melanoma Cells: Role of LEF-1 in Melanoma with Increased Metastatic Potential

https://doi.org/10.1006/bbrc.2001.5719Get rights and content

Abstract

A constitutive complex of β-catenin and LEF-1 has been detected in melanoma cell lines expressing either mutant β-catenin or mutant APC (Rubinfeld et al., Science, 275, 1790–1792, 1997). However, it has been recently reported that β-catenin mutations are rare in primary malignant melanoma, but its nuclear and/or cytoplasmic localization, a potential indicator of Wnt/β-catenin pathway activation, is frequently observed in melanoma (Rimm et al., Am. J. Pathol., 154, 325–329, 1999). In human malignant melanoma, the appearance of the tumorigenic phase represents a capacity for metastasis and is the significant phenotypic step in disease progression. Cell motility in invasive melanoma is thought to play a crucial role in metastatic behavior. In this work, we sought to determine which transcription factor of the LEF/TCF family was preferentially involved in human melanoma from different stages of tumor progression. We show that LEF-1 mRNA expression is predominant in highly migrating cells from metastatic melanomas. These actively migrating melanoma cells showed nuclear and cytoplasmic accumulation of β-catenin and active transcription from a reporter plasmid of the LEF/TCF binding site. These results may provide a new insight into the role of the Wnt/β-catenin signaling pathway in the tumor progression of malignant melanoma.

References (48)

  • G. Albrecht-Buehler

    The phagokinetic tracks of 3T3 cells

    Cell

    (1977)
  • H. Yamamoto et al.

    Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability

    J. Biol. Chem.

    (1999)
  • L. Zeng et al.

    The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation

    Cell

    (1997)
  • C.A. Erickson et al.

    Neural crest development: The interplay between morphogenesis and cell differentiation

    Curr. Topics Dev. Biol.

    (1998)
  • M. Peifer et al.

    Wnt signaling in oncogenesis and embryogenesis—A look outside the nucleus

    Science

    (2000)
  • R.S. Bradley et al.

    Expression of Wnt-1 in PC12 cells results in modulation of plakoglobin and E-cadherin and increased cellular adhesion

    J. Cell Biol.

    (1993)
  • L. Hinck et al.

    Wnt-1 modulates cell–cell adhesion in mammalian cells by stabilizing beta-catenin binding to the cell adhesion protein cadherin

    J. Cell Biol.

    (1994)
  • S. Munemitsu et al.

    Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein

    Proc. Natl. Acad. Sci. USA

    (1995)
  • B. Rubinfeld et al.

    Stabilization of beta-catenin by genetic defects in melanoma cell lines

    Science

    (1997)
  • P.J. Morin et al.

    Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

    Science

    (1997)
  • A. Travis et al.

    LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function

    Genes Dev.

    (1991)
  • M.L. Waterman et al.

    A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer

    Genes Dev.

    (1991)
  • J. Behrens et al.

    Functional interaction of beta-catenin with the transcription factor LEF-1

    Nature

    (1996)
  • Cited by (66)

    • Angel or Devil ? - CDK8 as the new drug target

      2021, European Journal of Medicinal Chemistry
      Citation Excerpt :

      The combination of WNT and Frizzled family receptor activates phosphorylation of drainheled (Dsh) and causes inactivation of GSK3β/APC/AXIN/β-catenin complex. The β-catenin released by the inactivated complex binds to TCF/LEF after be transferred into the nucleus and stimulates the TCF/LEF-dependent gene transcription [121–123]. In addition, E2F1 participates in controlling the cell cycle and the function of tumor suppressor genes.

    • Binding patterns and structure–activity relationship of CDK8 inhibitors

      2020, Bioorganic Chemistry
      Citation Excerpt :

      Melanoma is regulated by the histone variant mH2A, and downregulation of this histone variant correlates with disease severity. Up-regulation of CDK8 may augment treatment of melanoma [59,60], by compensating for the loss of function resulting from downregulation of mH2A. Leveraging this indirect function of CDK8 to treat specific cancers is a novel therapeutic avenue [61,62].

    • PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway

      2018, Biomedicine and Pharmacotherapy
      Citation Excerpt :

      These transformed the morphology of epithelial cells into mesenchymal cells to obtain the ability of migration [22–25]. Furthermore, the Wnt/β-catenin signaling pathway could induce EMT by inhibiting glycogen synthase kinase 3β-mediated phosphorylation and inhibiting the degradation of β-catenin, thereby promoting the migration and invasion of malignant tumor [24,26]. Given the promotion of TAMs on migration and invasion of tumor, we are interested in testing whether TAMs promote the migration and invasion of colon tumor, how the promotion is produced, and which signals are involved in this process.

    • Genetic Variants in WNT2B and BTRC Predict Melanoma Survival

      2017, Journal of Investigative Dermatology
    • Effects of Wnt-10b on proliferation and differentiation of murine melanoma cells

      2015, Biochemical and Biophysical Research Communications
    View all citing articles on Scopus
    1

    To whom correspondence should be addressed. Fax: +81-285-44-4857. E-mail: [email protected].

    View full text